Bank Julius Baer & Co’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Sell |
4,635
-207
| -4% | -$10.1K | ﹤0.01% | 437 |
|
|
2025
Q1 | $186K | Sell |
4,842
-19
| -0.4% | -$731 | ﹤0.01% | 428 |
|
|
2024
Q4 | $211K | Buy |
+4,861
| New | +$211K | ﹤0.01% | 422 |
|
|
2024
Q2 | – | Sell |
-130
| Closed | -$8.86K | – | 503 |
|
|
2024
Q1 | $8.86K | Hold |
130
| – | – | ﹤0.01% | 514 |
|
|
2023
Q4 | $8.14K | Sell |
130
-19,726
| -99% | -$1.23M | ﹤0.01% | 527 |
|
|
2023
Q3 | $901K | Buy |
19,856
+13,417
| +208% | +$609K | 0.01% | 267 |
|
|
2023
Q2 | $361K | Buy |
6,439
+5,137
| +395% | +$288K | ﹤0.01% | 369 |
|
|
2023
Q1 | $59K | Buy |
1,302
+345
| +36% | +$15.6K | ﹤0.01% | 512 |
|
|
2022
Q4 | $39K | Sell |
957
-14,499
| -94% | -$591K | ﹤0.01% | 516 |
|
|
2022
Q3 | $1.01M | Buy |
15,456
+154
| +1% | +$10.1K | 0.01% | 252 |
|
|
2022
Q2 | $930K | Buy |
15,302
+565
| +4% | +$34.3K | 0.01% | 285 |
|
|
2022
Q1 | $925K | Buy |
14,737
+11,253
| +323% | +$706K | 0.01% | 289 |
|
|
2021
Q4 | $264K | Buy |
+3,484
| New | +$264K | ﹤0.01% | 509 |
|
|
2021
Q1 | – | Sell |
-10,084
| Closed | -$1.54M | – | 830 |
|
|
2020
Q4 | $1.54M | Buy |
+10,084
| New | +$1.54M | 0.01% | 288 |
|